Site içinde arama yapın

Aarya Jain bir ses eklendi Health
2026-07-23 08:46:07 -

North America Gaucher Disease Treatment Market: Emerging Opportunities in Precision Medicine and Biopharmaceuticals
The increasing focus on rare disease management, innovative drug development, and personalized medicine is accelerating growth across the orphan drugs market, metabolic disorder therapeutics, and the broader rare disease pharmaceuticals market. Rare diseases often require specialized treatment approaches due to their complex genetic origins, limited patient populations, and...

0 Yorumlar 0 hisse senetleri 83 Views 0 önizleme

Please log in to like, share and comment!
Mahesh Chavan bir ses eklendi Other
2025-11-13 08:20:05 -

Continuous Manufacturing Market to Reach USD 1.79 Billion by 2033, Growing at 12.2% CAGR
Market Overview The global continuous manufacturing market size was valued at USD 0.63 billion in 2024 and It is projected to reach from USD 0.71 billion in 2025 to USD 1.79 billion by 2033, growing at a CAGR of 12.2% during the forecast period (2025–2033). The global Continuous Manufacturing market continues to evolve rapidly, driven by shifting...

0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme

Please log in to like, share and comment!
Amitmax Patil bir ses eklendi Other
2025-12-18 06:06:41 -

Humira Biosimilar Market Size to Reach USD 4.34 Million by 2032
According to a new report published by Introspective Market Research, Humira Biosimilar Market by Product Type, Indication, and Distribution Channel, The Global Humira Biosimilar Market Size Was Valued at USD 0.72 Billion in 2023 and is Projected to Reach USD 4.34 Million by 2032, Growing at a CAGR of 22.1%. Introduction / Market Overview The Humira Biosimilar Market is...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!
Mahesh Chavan bir ses eklendi Other
2025-11-13 08:04:23 -

Insulin Glargine Market to Reach USD 2.2 Billion by 2031, Growing at 6.11% CAGR
Market Overview The global insulin glargine market was valued at USD 1290 million in 2022. It is estimated to reach USD 2200 million by 2031, growing at a CAGR of 6.11% during the forecast period (2023–2031). The global Insulin Glargine market continues to evolve rapidly, driven by shifting consumer trends, rising investments, and technological progress....

0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme

Please log in to like, share and comment!